Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

PARP inhibitors in ovarian cancer: What are the next steps?

Date

10 Oct 2016

Session

Advances in targeted therapy in gynaecological cancers

Presenters

Jonathan Ledermann

Authors

J.A. Ledermann

Author affiliations

  • Cancer Research Uk And Ucl Cancer Trials Centre, University College London Cancer Institute, WC1E6BT - London/GB
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Resources from the same session

Cervical cancer therapy in 2016

Presenter: Mansoor Raza Mirza

Session: Advances in targeted therapy in gynaecological cancers

Resources:

Presentation

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings